ranitidine

(redirected from Zantac 75)
Also found in: Dictionary, Thesaurus.
Related to Zantac 75: Zantac 150

ranitidine

 [rah-nit´ĭ-dēn]
an antagonist of histamine H2receptors, used as the hydrochloride salt to inhibit stomach hydrochloric acid secretion in treatment of peptic ulcers, gastroesophageal reflux, and conditions of gastric hypersecretion, administered orally, intramuscularly, or intravenously.

ranitidine

/ra·ni·ti·dine/ (rah-nĭ´tĭ-dēn) a histamine H2 receptor antagonist, used as the hydrochloride salt to inhibit gastric acid secretion in the treatment of gastric and duodenal ulcer, gastroesophageal reflux disease, and conditions that cause gastric hypersecretion.

ranitidine

(rə-nĭt′ĭ-dēn′)
n.
A histamine receptor antagonist, C13H22N4O3that inhibits gastric acid secretion and is used primarily to treat duodenal ulcers, gastric ulcers, and gastroesophageal reflux disease.

ranitidine

[ranit′idēn]
a histamine H2 receptor antagonist.
indications It is prescribed in the treatment of gastroesophageal reflux disease and gastric hypersecretory conditions.
contraindications Known sensitivity to this drug prohibits its use. The drug should be used in pregnancy only if clearly needed and with caution in those with severe hepatic or renal impairment.
adverse effects Among the most serious adverse effects are acquired hemolytic anemia, agranulocytosis, atrioventricular block, agitation, dizziness, headaches, rashes, gynecomastia, and loss of libido.

ranitidine

Zantac Therapeutics An H2-receptor antagonist used to treat peptic ulcer disease, gastric and duodenal ulcers, esophageal erosions, GERD, and conditions–eg, Zollinger-Ellison disease and systemic mastocytosis in which there is ↑ H2 activity due to blocking of the binding of histamine to H2 receptors, resulting in ↓ intracellular concentration of cAMP and acid secretion by gastric parietal cells Adverse reactions Diarrhea, headache, fatigue, myalgia, constipation, confusion, agranulocytosis, gynecomastia, impotence, allergic reactions, tachycardia, arrhythmias, interstitial nephritis, etc. See H2 blockers, Histamine receptor antagonists.

ranitidine

An H-2 (histamine-2) receptor antagonist drug used to reduce acid secretion in cases of peptic ulceration. A band name is Zantac. See also RANTITIDINE BISMUTH CITRATE.

ranitidine

a histamine H2-blocking agent used in the treatment of gastric ulceration and chronic hypertrophic gastritis.
References in periodicals archive ?
The growth potential of the OTC business has not been lost on Warner-Lambert, particularly with regard to its recent launch of Zantac 75, an OTC H2 switch product introduced through the Glaxo Wellcome Warner-Lambert joint venture.
With the launch of Zantac 75, Warner-Lambert sought to improve its position as the fourth largest global marketer of OTC products.
In the time Zantac 75 has been launched, while mass started out with an edge from the first week, after the first seven weeks, the food channel gained in share while mass slipped.
The plunge in the sales of Zantac 75 may be explained in part by consumers' preference for the higher-strength Zantac 150, for which sales increased by nearly 7 % over the past year, according to IRI.
Prilosec's addition repeated a pattern experienced several years ago when a number of products, including Pepcid, Zantac 75 and Glaxo's Tagamet, made the transition from Rx to O-T-C status.
s Zantac 75, Johnson & Johnson Merck Consumer Pharmaceuticals' Pepcid AC and GlaxoSmithKline PLC's Tagamet HB 200 changed the way heartburn sufferers looked at antacids, Prilosec, the first product from a class of drugs known as proton pump inhibitors to be available without a prescription, has taken the category to a new level.
7% Best-sellers in drug stores * Dollar Dollar sales Brand Manufacturer market share (add 000) Zantac 75 Pfizer 11.
1%) Market Dollar sales Leading brands Manufacturer share ** (000) Zantac 75 Pfizer 5.
s Zantac 75, GlaxoSmithKline's Tagamet and Whitehall-Robins Healthcare's Axid--have changed the way consumers think about stomach remedies.